KMC SPECIALITY HOSPITALS (INDIA) LTD.

KMC Speciality Hospitals (India) Ltd has submitted a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, following discrepancies identified by BSE. The revisions address specific transaction dates for encumbrances, reasons for encumbrance, and the inclusion of both lender and trustee names. The company, through its holding company Sri Kauvery Medical Care (India) Limited, has aligned its disclosures with the updated SEBI circular format effective August 5, 2015. This action rectifies issues related to pre-event and post-event encumbered shareholdings and ensures compliance with regulatory requirements.

Sri Kauvery Medical Care (India) Limited, a promoter of KMC Speciality Hospitals (India) Limited, has disclosed the creation of an indirect encumbrance over 27,41,435 equity shares, representing 5.37% of the fully diluted shareholding. This encumbrance, created on September 4, 2026, is in the form of a pledge over shares of SKMCIL in favor of Catalyst Trusteeship Limited, acting as Debenture Trustee. The pledge serves as security for non-convertible debentures to be issued by Prospera Healthcorp Private Limited. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

KMC Speciality Hospitals (India) Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which is part of the Annual Report, details the company's corporate identity, business activities primarily in hospital and medical care services (100% of turnover), operational locations, employee turnover rates, and its holding company, Sri Kauvery Medical Care (India) Limited. It also confirms CSR applicability with a turnover of ₹305.77 Cr and net worth of ₹210.43 Cr, and notes the absence of complaints filed by community stakeholders.

KMC Speciality Hospitals (India) Ltd has announced its 43rd Annual General Meeting (AGM) scheduled for September 28, 2026, to be held via Video Conference (VC) / Other Audio Visual Means (OAVM). The company has engaged CDSL for e-voting services. The Annual Report for FY 2025-26, along with the AGM notice, has been sent to shareholders and is available on the company's website. Key financial highlights for FY 2025-26 include Revenue from Operations of ₹305.8 Cr, EBITDA of ₹93 Cr, and PAT of ₹46.73 Cr. The company also reported a hospital capacity of 450 beds, over 170 doctors, and 1695 employees.

KMC Speciality Hospitals (India) Ltd has announced the details for its 43rd Annual General Meeting (AGM), scheduled for September 28, 2026, at 10:30 AM IST. The meeting will be conducted via Video Conference (VC) / Other Audio Visual Means (OAVM), with e-voting services provided by CDSL. Key agenda items include the adoption of audited financial statements for FY26, the appointment of a director, and approval for material related party transactions with its holding company, Sri Kauvery Medical Care (India) Limited, up to ₹65 crore for FY27. The cut-off date for voting on AGM resolutions is September 21, 2026, with e-voting commencing on September 25 and ending on September 27, 2026.

KMC Speciality Hospitals (India) Ltd announced board approval for significant capacity expansion projects in Trichy and Bengaluru. The Trichy campus expansion includes adding four floors to the Mother & Child Care Hospital and constructing a new Super-Speciality Block, aiming to add approximately 500 beds at a cost of ₹486 crores. The Bengaluru project involves a dedicated Mother & Child Hospital on leased premises, adding around 91 beds for ₹33 crores. The company also appointed M/s. G Sugumar & Co as its Cost Auditor for FY 2026-27. The Trichy expansion is planned in two phases, with commissioning expected in Q4 FY'28 and Q2 FY'30, while the Bengaluru unit is slated for Q2 FY'28.

KMC Speciality Hospitals (India) Ltd announced its standalone unaudited financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors at a meeting held on August 14, 2026. The company submitted these results along with the Limited Review Report from its statutory auditors, Deloitte Haskins & Sells. The financial statements have been prepared in accordance with Indian Accounting Standard 34 and comply with SEBI Listing Regulations.

KMC Speciality Hospitals (Kauvery Hospital, Trichy) reported standalone Q1 FY27 revenue from operations of ₹91.78 Cr, up 37.9% YoY from ₹66.55 Cr and up 11.6% QoQ from ₹82.25 Cr. Standalone PAT more than doubled YoY to ₹16.57 Cr from ₹7.54 Cr (+119.9%), and rose 13.3% QoQ from ₹14.63 Cr, with EPS at ₹1.02 versus ₹0.46 a year ago and ₹0.90 last quarter. There are no exceptional or one-off items disclosed in either period, so the YoY jump is organic rather than a base-effect artefact. The profit growth was driven by operating leverage: total expenses rose 24.1% YoY (₹71.15 Cr vs ₹57.35 Cr) while total income rose 39.0% YoY, so operating profit margin (EBITDA/revenue) expanded to 31.0% from 24.7% a year ago, and net profit margin expanded to 17.7% from 11.2%. Employee benefits expense (+27.6% YoY) and other expenses (+28.0% YoY) grew broadly in line with volumes, but finance costs actually declined YoY (₹2.00 Cr vs ₹2.16 Cr) despite the larger revenue base, adding directly to the bottom line. Sequentially margins were roughly flat-to-softer (OPM 31.0% now vs 31.5% in Q4 FY26), so the YoY expansion is the more meaningful signal per our comparison hierarchy. There is no formal management guidance on record from our database or the filing, and no analyst/brokerage consensus or Q1 preview could be found for this stock in web search — as a small, single-facility standalone hospital company it does not appear to carry formal sell-side coverage, so both vs-guidance and vs-street are unknown rather than beat/miss. The filing itself carries no MD&A or press-release commentary beyond the standard boilerplate notes (single-segment disclosure, review report details), so there is no management framing to reconcile against the numbers this quarter. Separately, the company disclosed promoter share encumbrances on August 5 and August 12, 2026, just ahead of this result — a shareholding-pattern item unrelated to the operating print but worth flagging as it surfaced in the same week.

Catalyst Trusteeship Ltd, acting as Debenture Trustee for Prospera Healthcorp Private Limited, has filed a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This filing pertains to the creation of a pledge over 14.53% and a non-disposal undertaking over 32.40% of the shareholding in Sri Kauvery Medical Care (India) Limited (SKMCIL). SKMCIL, in turn, holds a 75% stake in KMC Speciality Hospitals (India) Limited. The total encumbrance on SKMCIL's shares amounts to 46.93%. This action is taken for the benefit of debenture holders under a debenture trust deed. The disclosure is made towards indirect encumbrance on KMC Speciality Hospitals (India) Limited.

KMC Speciality Hospitals (India) Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. This notification is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.